January 26, 2026
1 min read

Responding to tougher FDA standards, Recipharm debuts new facility for beta-lactam drugs

Juggling a mix of customer demand and new regulations, Recipharm has built out a new facility in Bengaluru, India, to produce nonbacterial beta-lactam tablets. By commissioning the plant, Recipharm says it has lassoed up a “major partnership” with an unnamed, “leading innovative biopharmaceutical company” to help produce the partner’s non-bacterial beta-lactam tablets.

Leave a Reply

Your email address will not be published.

Previous Story

From nutrition to sustainability: tackling plastic pollution through Plumpy’Nut sachet recovery in Chad and Burkina Faso

Next Story

STAT+: Endometriosis often takes years to diagnose. Startups want to change that

Previous Story

From nutrition to sustainability: tackling plastic pollution through Plumpy’Nut sachet recovery in Chad and Burkina Faso

Next Story

STAT+: Endometriosis often takes years to diagnose. Startups want to change that

Latest from Blog

Go toTop